U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07604974) titled 'A Study to Assess the Safety, Tolerability and Efficacy of ION775' on May 18.
Brief Summary: The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Hypertriglyceridemia
Severe Hypertriglyceridemia
Intervention:
DRUG: ION775
ION775 will be administered by SC injection.
Recruitment Status: RECRUITING
Sponsor: Ionis Pharmaceuticals, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....